SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009137
Filing Date
2022-05-11
Accepted
2022-05-11 07:10:46
Documents
15
Period of Report
2022-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tngx-20220511.htm   iXBRL 8-K 50419
2 EX-99.1 tngx-ex99_1.htm EX-99.1 212604
3 GRAPHIC img21139354_0.jpg GRAPHIC 26351
4 GRAPHIC img159112069_0.jpg GRAPHIC 778
  Complete submission text file 0000950170-22-009137.txt   438190

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tngx-20220511_lab.xml EX-101.LAB 14811
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tngx-20220511.xsd EX-101.SCH 2487
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tngx-20220511_pre.xml EX-101.PRE 11485
9 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20220511_htm.xml XML 4883
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 22912049
SIC: 2834 Pharmaceutical Preparations